medigraphic.com
ISSN 1405-8871 (Print)

2017, Number 1

<< Back Next >>

Aten Fam 2017; 24 (1)

Smoking and Atypia Cervix-Vaginal Cell

Sánchez-Hernández JA, García-Amaya CV, Muñoz-Zurita G

Language: Spanish
References: 25
Page: 3-7
PDF size: 589.41 Kb.


ABSTRACT

Objective: to identify the correlation between smoking and atypia cervix-vaginal cells. Methods: it was performed an exfoliative cytology cervix-vaginal (pap) to 807 patients in the Laboratory of Cellular Biology of the Faculty of Medicine of the University Autonomous of Puebla between March of 2011 and March of 2016. It was also conducted gynecological interrogation and on the habit of smoking. Results: of the 807 patients, 178 gave positive to smoking, some atypia cells were reported in the Cytology results. A reason of odds was made giving as result 1.9 and probability of 65% in smokers with atypia cell types liebg and lieag. Conclusion: this drug addiction is a predisposing factor in the emergence of atypia cervix-vaginal cells, due to the large amount of toxic chemicals and carcinogens contained in cigarette.


REFERENCES

  1. Grases PJ, Tresserra CF, López ML. Cuello uterino: atipias y lesiones premalignas no invasoras. Rev Obstet, Ginecol. Venez. 2006;66(2):82-7.

  2. Macêdo BAC, Adad SJ, Michelin MA, Murta EFC. Atypical squamous cells of undetermined significance: analysis of microbiology, cytological criteria and clinical conduct. Tumori. 2006;92:213-7.

  3. Vivar N. Sistema Bethesda: Citología Cérvico-vaginal. InfoNet-L@b [Internet]. 2006;1:1. Disponible en: http://www.netlab.com.ec/documentos/BOLETIN1-06.pdf

  4. Saad RS, Dabbs DJ, Kordunsky L, Kanbour SA, Silverman JF, Liu Y, et al. Clinical Significance of Cytologic Diagnosis of Atypical Squamous Cells, Cannot Exclude High Grade, in Perimenopausal and Postmenopausal Women. Am J Clin Pathol. 2006;126:381.

  5. De San José LS, García GAM. Virus del Papiloma Humano y Cáncer: Epidemiología y Prevención. Soc Esp Epidemiol. 2006;4(9):15-30.

  6. Velázquez OE. 20 respuestas para cáncer cérvico-uterino. Mé xico: Vergara/Ediciones B; 2011. 1-7.

  7. Chaturvedi AK, Kleinerman RA, Hildesheim AG, Strom H, Lynch CF, Hall P, et al. Second Cancers After Squamous Cell Carcinoma and Adenocarcinoma of the Cervix. J Clin Oncol. 2009;27(6):967.

  8. Sait K, Bentley J, Anfinan N, Power P. Cervical Cancer Prevention in Saudi Arabia: It is Time to Call for Action! The open Women’s. Health Journal. 2012;6:1.

  9. Sánchez HJA, Varela SO, Gómez LC, Islas DG, Pezzad SEB, Martínez HJF, et al. Relación entre vih y vph: Estudio de 40 casos. Rev Med uas. 2011;2(2):45-6.

  10. Wiley DJ, Wiesmeier E, Masongsong E, Gylys KH, Koutsky LA, Ferris DG, et al. The Proof of Principle Study Investigative Group. Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 Infection. Cancer Epidemiol Biomarkers. Prev Amer Assoc Cancer Res. 2006;15(5):915-8.

  11. Collins S, Rollason TP, Lawrence SY, Woodman CBJ. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study. Eur J Cancer. 2010;16:405-9.

  12. Sasieni P, Castanon A, Snow J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. bmj. 2009;399(b2968):6.

  13. Fiander AN. Cervical screening in young women aged 20-24 years. J Fam Plann Reprod Health Care. 2008;34(1):19.

  14. Madsen BS, Jensen HL, Van der Brule AJC, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina—Population-based case–control study in Denmark. Int J Cancer. 2008;122:2834.

  15. Khan K, Robinette CC, Ekwueme DU, Stokley S, Walker C, Roland K, et al. Preventing Cervical Cancer, Overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US Immunization Programs. Amer. Cancer Soc. 2008;113(10):3004.

  16. López OJ. Infecciones vaginales y lesiones celulares cervicales (I). Programa de cribado de otras infecciones y ets simultáneas. Clín Invest Ginecol Obst. 2011;30(20):4.

  17. Otavio SL, Serpa HL, Longatto FA, Guarisi R, Derchain SFM, Roteli MC, et al. Increased Risk of Oncogenic Human Papillomavirus Infections and Incident High-Grade Cervical Intraepithelial Neoplasia Among Smokers, Experience From the Latin American Screening Study. Sex Transm Dis. 2009;36(4):241-2.

  18. Secretaría de Salud Púbica de México. Programa Nacional de Salud 2007-2012. 2007:44.

  19. Eriksen M, Mackay J, Ross H. The Tobacco Atlas. Amer Cancer Soc and World Lung Foundation. 2012;4(1):6-28.

  20. inegi. Estadísticas a propósito del día mundial sin tabaco, datos nacionales. inegi México. 2012:1.

  21. Nachón GMG, García RME, Nachón GFJ, Hernández PTG, Hernández LG. Tabaquismo y cáncer bucal: una revisión teórica. Rev Med uv. 2010:31-2.

  22. A. Shah C, A. Goff B, Lowe K, et al. Factors Affecting Risk of Mortality in Women With Vaginal Cancer. Obstet Gynecol. 2009;113(5):1039.

  23. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603-9.

  24. Wang MY, Nawal LM, Weidenbacher HV, Anderson G, West BJ. Antioxidant Activity of Noni Juice in Heavy Smokers. Chem Central J. 2009;3(13):1.

  25. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger RE, Lawson HW. Cervical Cancer Incidence in a Prevaccine Era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2-1):360.




2020     |     www.medigraphic.com